Efgartigimod as a promising add-on therapy for myasthenic crisis: a prospective case series

IntroductionEfgartigimod is effective and well-tolerated in patients with anti-acetylcholine receptor (AChR) antibody-positive generalized myasthenia gravis (MG). However, the therapeutic potential and the safety profile of efgartigimod in myasthenic crisis (MC) remained largely unknown.MethodsThis...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Jie Song, Haiyan Wang, Xiao Huan, Qilong Jiang, Zongtai Wu, Chong Yan, Jianying Xi, Chongbo Zhao, Huiyu Feng, Sushan Luo
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Frontiers Media S.A. 2024-07-01
Ráidu:	Frontiers in Immunology
Fáttát:	myasthenic crisis efgartigimod ventilation respiratory muscle antibody immunoglobulin G
Liŋkkat:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1418503/full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!